ArticleJCO precision oncology2026

Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

Hannah E Hartley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.